BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 745K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

Advanced Search

17 articles for L Weizel

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
N-Benzylbenzamides: A Novel Merged Scaffold for Orally Available Dual Soluble Epoxide Hydrolase/Peroxisome Proliferator-Activated Receptor¿ Modulators.EBI
Goethe-University Frankfurt
Studies on molecular properties prediction and histamine H3 receptor affinities of novel ligands with uracil-based motifs.EBI
University of Catania
Benzylpiperidine variations on histamine H3 receptor ligands for improved drug-likeness.EBI
Johann Wolfgang Goethe University
Non-imidazole histamine H3 receptor ligands incorporating antiepileptic moieties.EBI
United Arab Emirates University
Synthesis and evaluation of novel ligands for the histamine H4 receptor based on a pyrrolo[2,3-d]pyrimidine scaffold.EBI
Ku Leuven
Potential utility of histamine H3 receptor antagonist pharmacophore in antipsychotics.EBI
Johann Wolfgang Goethe Universit£T
Histamine H3 and H4 receptor affinity of branched 3-(1H-imidazol-4-yl)propyl N-alkylcarbamates.EBI
Jagiellonian University Medical College
2,4-Diaminopyrimidines as histamine H4 receptor ligands--Scaffold optimization and pharmacological characterization.EBI
Johann Wolfgang Goethe University
Designing a Small Fluorescent Inhibitor to Investigate Soluble Epoxide Hydrolase Engagement in Living Cells.EBI
Goethe University Frankfurt
-Aryl mercaptoacetamides as potential multi-target inhibitors of metallo-β-lactamases (MBLs) and the virulence factor LasB from EBI
Helmholtz Institute For Pharmaceutical Research Saarland (Hips)
Structure-Based Design of Dual Partial Peroxisome Proliferator-Activated Receptor γ Agonists/Soluble Epoxide Hydrolase Inhibitors.EBI
Goethe-University
-Aryl Mercaptopropionamides as Broad-Spectrum Inhibitors of Metallo-β-Lactamases.EBI
Helmholtz Institute For Pharmaceutical Research Saarland
Combined Cardioprotective and Adipocyte Browning Effects Promoted by the Eutomer of Dual sEH/PPARγ Modulator.EBI
Goethe University
Second-Generation Dual FXR/sEH Modulators with Optimized Pharmacokinetics.EBI
Goethe University Frankfurt
Design, Synthesis, and Structure-Activity Relationship Studies of Dual Inhibitors of Soluble Epoxide Hydrolase and 5-Lipoxygenase.EBI
Goethe-University of Frankfurt
Boosting Anti-Inflammatory Potency of Zafirlukast by Designed Polypharmacology.EBI
Goethe University Frankfurt
A Dual Modulator of Farnesoid X Receptor and Soluble Epoxide Hydrolase To Counter Nonalcoholic Steatohepatitis.EBI
Goethe-University Frankfurt